[Research advances on alpha-fetoprotein physiological function and clinical potential]
- PMID: 12561448
[Research advances on alpha-fetoprotein physiological function and clinical potential]
Abstract
Alpha-fetoprotein (AFP), a tumor-associated fetal protein, has been employed as a serum fetal defect/tumor marker to monitor disease progression. Besides this, AFP has many important physiological functions. As a tool of binding and transporting ligands, AFP may bind and transport fatty acids, steroids, heavy metal ions, drugs and some environmental contaminants. As a growth regulator, AFP is capable of both enhancement and inhibition. This function is dose-dependent. The regulatory mechanisms might involve apoptotic regulation, cytoplasmic signaling modulation, and receptor desensitization. As an anticancer drugs-ligand carrier, AFP can transport drugs into target tumor cells by binding AFP receptors overexpressed in the surface of tumor cells, and thus increase antitumor efficiency. In addition, AFP can be employed to chemoprevent breast cancer and possibly other tumors on the basis of its growth suppressive properties.
Similar articles
-
Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.Cell Biol Int. 2004;28(12):913-33. doi: 10.1016/j.cellbi.2004.09.005. Cell Biol Int. 2004. PMID: 15566961 Review.
-
Isolation and structural and functional characterization of two stable peptic fragments of human alpha-fetoprotein.Biochemistry. 1999 Aug 10;38(32):10406-14. doi: 10.1021/bi990630h. Biochemistry. 1999. PMID: 10441135
-
The physicochemical and biological properties of alpha-fetoprotein depend of its ligand environment.J Nucl Med Allied Sci. 1989 Jul-Sep;33(3 Suppl):18-26. J Nucl Med Allied Sci. 1989. PMID: 2480415 Review.
-
Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcription/growth factors.Med Hypotheses. 2002 Jun;58(6):453-61. doi: 10.1054/mehy.2001.1445. Med Hypotheses. 2002. PMID: 12323110
-
Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.Clin Cancer Res. 2005 Dec 1;11(23):8512-20. doi: 10.1158/1078-0432.CCR-05-1651. Clin Cancer Res. 2005. PMID: 16322315
Cited by
-
Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma.Front Physiol. 2018 Jul 17;9:930. doi: 10.3389/fphys.2018.00930. eCollection 2018. Front Physiol. 2018. PMID: 30065664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials